297 related articles for article (PubMed ID: 9106245)
1. Analysis of hprt mutations occurring in human TK6 lymphoblastoid cells following exposure to 1,2,3,4-diepoxybutane.
Steen AM; Meyer KG; Recio L
Mutagenesis; 1997 Mar; 12(2):61-7. PubMed ID: 9106245
[TBL] [Abstract][Full Text] [Related]
2. Characterization of hprt mutations following 1,2-epoxy-3-butene exposure of human TK6 cells.
Steen AM; Meyer KG; Recio L
Mutagenesis; 1997 Sep; 12(5):359-64. PubMed ID: 9379915
[TBL] [Abstract][Full Text] [Related]
3. Mutations induced by 1,3-butadiene metabolites, butadiene diolepoxide, and 1,2,3,4-diepoxybutane at the Hprt locus in CHO-K1 cells.
Lee DH; Kim TH; Lee SY; Kim HJ; Rhee SK; Yoon B; Pfeifer GP; Lee CS
Mol Cells; 2002 Dec; 14(3):411-9. PubMed ID: 12521305
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the mutations at Hprt exon 3 of T-lymphocytes from B6C3F1 mice and F344 rats exposed by inhalation to 1,3-butadiene or the racemic mixture of 1,2:3,4-diepoxybutane.
Meng Q; Singh N; Heflich RH; Bauer MJ; Walker VE
Mutat Res; 2000 Jan; 464(2):169-84. PubMed ID: 10648904
[TBL] [Abstract][Full Text] [Related]
5. Mutational spectrum of 1,3-butadiene and metabolites 1,2-epoxybutene and 1,2,3,4-diepoxybutane to assess mutagenic mechanisms.
Recio L; Steen AM; Pluta LJ; Meyer KG; Saranko CJ
Chem Biol Interact; 2001 Jun; 135-136():325-41. PubMed ID: 11397399
[TBL] [Abstract][Full Text] [Related]
6. Mutagenicity of butadiene and its epoxide metabolites: I. Mutagenic potential of 1,2-epoxybutene, 1,2,3,4-diepoxybutane and 3,4-epoxy-1,2-butanediol in cultured human lymphoblasts.
Cochrane JE; Skopek TR
Carcinogenesis; 1994 Apr; 15(4):713-7. PubMed ID: 8149485
[TBL] [Abstract][Full Text] [Related]
7. Mutagenicity of stereochemical configurations of 1,2-epoxybutene and 1,2:3,4-diepoxybutane in human lymphblastoid cells.
Meng Q; Redetzke DL; Hackfeld LC; Hodge RP; Walker DM; Walker VE
Chem Biol Interact; 2007 Mar; 166(1-3):207-18. PubMed ID: 16854403
[TBL] [Abstract][Full Text] [Related]
8. 1,3-butadiene: cancer, mutations, and adducts. Part II: Roles of two metabolites of 1,3-butadiene in mediating its in vivo genotoxicity.
Recio L; Saranko CJ; Steen AM
Res Rep Health Eff Inst; 2000 Mar; (92):49-87; discussion 141-9. PubMed ID: 10925839
[TBL] [Abstract][Full Text] [Related]
9. Molecular analysis of hprt mutant lymphocytes from 1, 3-butadiene-exposed workers.
Ma H; Wood TG; Ammenheuser MM; Rosenblatt JI; Ward JB
Environ Mol Mutagen; 2000; 36(1):59-71. PubMed ID: 10918361
[TBL] [Abstract][Full Text] [Related]
10. Molecular analysis of hprt mutants induced by 2-cyanoethylene oxide in human lymphoblastoid cells.
Recio L; Simpson D; Cochrane J; Liber H; Skopek TR
Mutat Res; 1990 Nov; 242(3):195-208. PubMed ID: 2270092
[TBL] [Abstract][Full Text] [Related]
11. Mutagenicity of butadiene and its epoxide metabolites: II. Mutational spectra of butadiene, 1,2-epoxybutene and diepoxybutane at the hprt locus in splenic T cells from exposed B6C3F1 mice.
Cochrane JE; Skopek TR
Carcinogenesis; 1994 Apr; 15(4):719-23. PubMed ID: 8149486
[TBL] [Abstract][Full Text] [Related]
12. Mutagenicity of stereochemical configurations of 1,3-butadiene epoxy metabolites in human cells.
Meng RQ; Hackfeld LC; Hedge RP; Wisse LA; Redetzke DL; Walker VE;
Res Rep Health Eff Inst; 2010 Jun; (150):1-34; discussion 35-41. PubMed ID: 20853577
[TBL] [Abstract][Full Text] [Related]
13. Molecular analysis of mutations at the HPRT and TK loci of human lymphoblastoid cells after combined treatments with 3'-azido-3'-deoxythymidine and 2',3'-dideoxyinosinedagger.
Meng Q; Su T; O'Neill JP; Walker VE
Environ Mol Mutagen; 2002; 39(4):282-95. PubMed ID: 12112380
[TBL] [Abstract][Full Text] [Related]
14. Nitric oxide-induced mutations in the HPRT gene of human lymphoblastoid TK6 cells and in Salmonella typhimurium.
Zhuang JC; Wright TL; deRojas-Walker T; Tannenbaum SR; Wogan GN
Environ Mol Mutagen; 2000; 35(1):39-47. PubMed ID: 10692226
[TBL] [Abstract][Full Text] [Related]
15. Mutational spectrum of ICR-191 at the hprt locus in human lymphoblastoid cells.
Taft SA; Liber HL; Skopek TR
Environ Mol Mutagen; 1994; 23(2):96-100. PubMed ID: 8143707
[TBL] [Abstract][Full Text] [Related]
16. 1,3-butadiene: cancer, mutations, and adducts. Part III: In vivo mutation of the endogenous hprt genes of mice and rats by 1,3-butadiene and its metabolites.
Walker VE; Meng Q
Res Rep Health Eff Inst; 2000 Mar; (92):89-139; discussion 141-9. PubMed ID: 10925840
[TBL] [Abstract][Full Text] [Related]
17. Genotoxicity of 1,3-butadiene and its epoxy intermediates.
Walker VE; Walker DM; Meng Q; McDonald JD; Scott BR; Seilkop SK; Claffey DJ; Upton PB; Powley MW; Swenberg JA; Henderson RF;
Res Rep Health Eff Inst; 2009 Aug; (144):3-79. PubMed ID: 20017413
[TBL] [Abstract][Full Text] [Related]
18. Mutagenicity of 1,3-butadiene and its epoxide metabolites in human TK6 cells and in splenic T cells isolated from exposed B6C3F1 mice.
Cochrane JE; Skopek TR
IARC Sci Publ; 1993; (127):195-204. PubMed ID: 8070866
[TBL] [Abstract][Full Text] [Related]
19. Molecular analysis of lacI mutants from transgenic fibroblasts exposed to 1,2-epoxybutene.
Saranko CJ; Pluta LJ; Recio L
Carcinogenesis; 1998 Nov; 19(11):1879-87. PubMed ID: 9854997
[TBL] [Abstract][Full Text] [Related]
20. Characterization of hprt splicing mutations induced by the ultimate carcinogenic metabolite of benzo[a]pyrene in Chinese hamster V-79 cells.
Hennig EE; Conney AH; Wei SJ
Cancer Res; 1995 Apr; 55(7):1550-8. PubMed ID: 7882364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
